Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Stop me if you've heard this one . . .

Stop me if you've heard this one . . .

For CEOs, investor relations specialists and PR types who suffer from writer's block or a sudden loss for words, here's a handy list of biotech cliches that have been proven through constant use as the leading platitudes in the field today. BioCentury is indebted to Jacqueline Siegel, biotech analyst at Gerard Klauer Mattison, for initiating this project with her own compilation of cliches. BioCentury has added a few of its

Read the full 801 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers